130 related articles for article (PubMed ID: 21502798)
1. Complete biochemical control and pituitary adenoma disappearance in a child with gigantism: efficacy of octreotide therapy.
Ciresi A; Amato MC; Galluzzo A; Giordano C
J Endocrinol Invest; 2011 Feb; 34(2):162-3. PubMed ID: 21502798
[No Abstract] [Full Text] [Related]
2. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy.
Schoof E; Dörr HG; Kiess W; Lüdecke DK; Freitag E; Zindel V; Rascher W; Dötsch J
Horm Res; 2004; 61(4):184-9. PubMed ID: 14739526
[TBL] [Abstract][Full Text] [Related]
3. Proliferation activity in somatotroph pituitary adenomas.
Delgrange E; Donckier J
Mayo Clin Proc; 1998 Oct; 73(10):1027-8. PubMed ID: 9787756
[No Abstract] [Full Text] [Related]
4. Gigantism with pituitary macroadenoma: an unusual variant of McCune-Albright syndrome.
Queirolo S; Gallarotti F; Capuano E; Garrè ML; Spaziante R; Di Battista E
J Pediatr Endocrinol Metab; 2009 Feb; 22(2):177-9. PubMed ID: 19449675
[No Abstract] [Full Text] [Related]
5. Long-term effects of octreotide on pituitary gigantism: its analgesic action on cluster headache.
Otsuka F; Mizobuchi S; Ogura T; Sato K; Yokoyama M; Makino H
Endocr J; 2004 Oct; 51(5):449-52. PubMed ID: 15516776
[TBL] [Abstract][Full Text] [Related]
6. Long-acting peptidomimergic control of gigantism caused by pituitary acidophilic stem cell adenoma.
Maheshwari HG; Prezant TR; Herman-Bonert V; Shahinian H; Kovacs K; Melmed S
J Clin Endocrinol Metab; 2000 Sep; 85(9):3409-16. PubMed ID: 10999842
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR.
Resmini E; Murialdo G; Giusti M; Boschetti M; Minuto F; Ferone D
J Endocrinol Invest; 2005 Feb; 28(2):166-9. PubMed ID: 15887864
[TBL] [Abstract][Full Text] [Related]
8. TSH-secreting pituitary macroadenoma: rapid tumor shrinkage and recovery from hyperthyroidism with octreotide.
Fischler MP; Reinhart WH
J Endocrinol Invest; 1999 Jan; 22(1):64-5. PubMed ID: 10090139
[TBL] [Abstract][Full Text] [Related]
9. [Hypophyseal thyrotropin adenomas at Yaounde (Cameroon). Analysis of two case reports: improvement with somatostatin analogue (SMS 201-995)].
Nouedoui C; Moukouri E; Juimo AG; Dongmo L; Zok FD; Tapko JB; Muna WF
Tunis Med; 1999 Mar; 77(3):154-8. PubMed ID: 10392035
[No Abstract] [Full Text] [Related]
10. Pituitary gigantism caused by growth hormone excess from infancy.
Gelber SJ; Heffez DS; Donohoue PA
J Pediatr; 1992 Jun; 120(6):931-4. PubMed ID: 1593354
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effect of octreotide in somatotroph pituitary adenomas: discussion from a single case report.
Delgrange E; Trouillas J; Gustin T; Gilliard C; Donckier JE
Acta Neurochir (Wien); 2001; 143(7):733-6. PubMed ID: 11534696
[TBL] [Abstract][Full Text] [Related]
12. Ectopic growth hormone-secreting pituitary adenoma involving the clivus treated with octreotide: role of magnetic resonance imaging in the diagnosis and clinical follow-up.
Ferraz-Filho JR; Torres US; Teixeira AC; Castro ML; Dias MA
Arq Neuropsiquiatr; 2012 Sep; 70(9):744-5. PubMed ID: 22990736
[No Abstract] [Full Text] [Related]
13. Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre.
Abe T; Lüdecke DK
Eur J Endocrinol; 2001 Aug; 145(2):137-45. PubMed ID: 11454508
[TBL] [Abstract][Full Text] [Related]
14. Long-term octreotide therapy in growth hormone-secreting pituitary adenomas: evaluation with serial MR.
Lundin P; Edén Engström B; Karlsson FA; Burman P
AJNR Am J Neuroradiol; 1997 Apr; 18(4):765-72. PubMed ID: 9127047
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effect of the somatostatin analogue octreotide on growth hormone-producing pituitary tumors: results of a multicenter randomized trial.
Thapar K; Kovacs KT; Stefaneanu L; Scheithauer BW; Horvath E; Lloyd RV; Li J; Laws ER
Mayo Clin Proc; 1997 Oct; 72(10):893-900. PubMed ID: 9379690
[TBL] [Abstract][Full Text] [Related]
16. Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection.
Mozas J; Ocón E; López de la Torre M; Suárez AM; Miranda JA; Herruzo AJ
Int J Gynaecol Obstet; 1999 Apr; 65(1):71-3. PubMed ID: 10390105
[TBL] [Abstract][Full Text] [Related]
17. Pharyngeal pituitary non-functioning adenoma with normal intra-sellar gland: massive tumor shrinkage on octreotide therapy.
Pugnale N; Waridel F; Bouzourène H; Boubaker A; Pugnale M; Gaillard RC; Gomez F
Eur J Endocrinol; 2003 Mar; 148(3):357-64. PubMed ID: 12611618
[TBL] [Abstract][Full Text] [Related]
18. Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation.
Gruszka A; Zielinski GM; Kunert-Radek J
J Clin Neurosci; 2014 Feb; 21(2):340-2. PubMed ID: 23958483
[TBL] [Abstract][Full Text] [Related]
19. Treatment of thyrotropin-secreting pituitary adenomas with octreotide.
Shimatsu A; Murabe H; Kamoi K; Suzuki Y; Nakao K
Endocr J; 1999 Feb; 46(1):113-23. PubMed ID: 10426575
[TBL] [Abstract][Full Text] [Related]
20. Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl.
Rix M; Laurberg P; Hoejberg AS; Brock-Jacobsen B
Eur J Endocrinol; 2005 Aug; 153(2):195-201. PubMed ID: 16061823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
